Beijing Science Sun Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 192.1 million compared to CNY 233.13 million a year ago. Revenue was CNY 192.1 million compared to CNY 233.13 million a year ago. Net income was CNY 106.55 million compared to CNY 42.41 million a year ago. Basic earnings per share from continuing operations was CNY 0.22 compared to CNY 0.09 a year ago. Diluted earnings per share from continuing operations was CNY 0.22 compared to CNY 0.09 a year ago.